1 / 5

Biologics Market Advancements, Growth Opportunity and Forecast 2020-2027

Biologics Market<br>

swati15
Download Presentation

Biologics Market Advancements, Growth Opportunity and Forecast 2020-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biologics Market To Reach USD 625.6 Billion By 2026 www.reportsanddata.com

  2. Market Summary According to the current analysis of Reports and Data, the global Biologics market was valued at USD 251.5 Billion in 2018 and is expected to reach USD 625.6 Billion by the year 2026, at a CAGR of 11.9%. The study covers Biologics, a drug that contains living organisms or their specific components or by- products. Biologic medicines are usually injected into the patient’s body because of its large molecular size (200-1000x) and fragile molecular structure. Parts of organisms like their cells, tissues, recombinant proteins, genes, allergens, blood or blood components, and vaccines are used in biologic drugs. Biologics are used for the treatment of various diseases and conditions like anemia, cancer, and other autoimmune diseases. Biologics are changing the ways doctors treat common conditions that have plagued individuals for years. . Biologics have various potential advantages as they can, theoretically, be customized to hit specific ‘gene targets’ in the human body. AbbVie’s Humira (adalimumab) – a drug used to treat autoimmune disorders such as rheumatoid arthritis. Biologics products including those which are manufactured by biotechnology are heat sensitive and susceptible to contamination. Hence, it is essential to maintain aseptic condition from initial manufacturing process till the end of the production, Biologic drugs have witnessed a significant success rate, notably in cancer and autoimmune diseases. www.reportsanddata.com Read More: https://www.reportsanddata.com/report-detail/biologics-market

  3. Market Summary Further key findings from the report suggest • On the basis of application, Cancer is expected to be the fastest growing market segment during forecast period 2019-2026 with a CAGR of 12.4%.The key factor responsible for the growth of the segment is predominant rise in cancer and geriatric population worldwide. • Cancer application segment holds a market share of 42.2% followed by autoimmune diseases and infectious diseases holding 35.9% and 14.6% respectively. • Asia Pacific is expected to account for the 21.4% of the global Biologics market due to the large prevalence of target diseases in countries like India and China. • Stringent government regulations and associated side effects like gastrointestinal complications, change in blood pressure, chest pain, breathing problems etc. are the key challenges faced by the Biologics market players. • Key participants include Merck & Co. Inc., AbbVie, Inc., AstraZeneca Plc., Amgen, Inc., Celgene Corporation, Bristol-Myers Squibb Co., Eli Lilly and Company, Janssen Pharmaceuticals, Inc., GlaxoSmithKline Plc., Novartis AG, Pfizer, Inc., and Novo Nordisk A/S. www.reportsanddata.com

  4. Market Summary For the purpose of this report, Reports and Data has segmented the Biologics market on the basis of product, application, end use and region: • Product type Outlook (Revenue, USD Million; 2016-2026) • Monoclonal Antibodies Vaccines Recombinant Hormones/Proteins Cellular Based Biologics Gene Based Biologics • • • • • www.reportsanddata.com Application Outlook (Revenue, USD Million; 2016-2026) • Cancer Infectious Diseases Autoimmune diseases Others • • • •

  5. About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. Contact US Contact US We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. www.reportsanddata.com John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related